Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PEPD | P12955 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20680 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL1805083 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL38660911 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL150816 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL1680973 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL2515289 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL150817 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL23573909 | 0.97 | PEPD (0.52) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL1964404 | 0.97 | PEPD (0.52) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL20603957 | 0.97 | PEPD (0.52) | PEPDALDH1A1LMNAMEN1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115725064-B | Preparation method of polycarbonate with main chain containing parallel ring structure | 四川大学 | 2024-04-12 | — | — | CN | disclosed |
| CN-117285530-A | New preparation method of lurasidone hydrochloride | 迪嘉药业集团股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-115725064-A | Preparation method of polycarbonate with main chain containing parallel-ring structure | 四川大学 | 2023-03-03 | — | — | CN | disclosed |
| EP-3854471-A1 | IMPROVEMENTS RELATING TO WATER PURIFICATION | Molecule RND Limited (IE) | 2021-07-28 | — | — | EP | disclosed |
| WO-2020021112-A1 | IMPROVEMENTS RELATING TO WATER CAPTURE | UNIVERSITY OF LIMERICK (IE) | 2020-01-30 | — | — | WO | disclosed |
| WO-2016085634-A1 | PROCESS FOR EXTRUDING POLYPROPYLENE | MILLIKEN & COMPANY (US) | 2016-06-02 | — | — | WO | disclosed |
| WO-2016085633-A1 | PROCESS FOR EXTRUDING POLYPROPYLENE | MILLIKEN & COMPANY (US) | 2016-06-02 | — | — | WO | disclosed |
| WO-2014102808-A1 | A PROCESS FOR PREPARATION OF TRANS (LR,2R)-CYCLO HEXANE 1, 2-DICARBOXYLIC ACID | LEE PHARMA LIMITED (IN) | 2014-07-03 | — | — | WO | disclosed |
| US-8735582-B2 | Method for producing carboxylic anhydride and arylboronic acid compound | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2014-05-27 | — | — | US | disclosed |
| US-20110319620-A1 | METHOD FOR PRODUCING CARBOXYLIC ANHYDRIDE AND ARYLBORONIC ACID COMPOUND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2011-12-29 | — | — | US | disclosed |
| WO-2009001128-A1 | 1,2-CYCL0HEXANE DICARBOXAMIDES AS CATHEPSIN INHIBITORS | ASTRAZENECA AB (SE) | 2008-12-31 | — | — | WO | disclosed |
| US-6995177-B1 | HCV NS3 protease inhibitors | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) | 2006-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319620-A1 | METHOD FOR PRODUCING CARBOXYLIC ANHYDRIDE AND ARYLBORONIC ACID COMPOUND | CA6, CA9, APEH | PEPD 264/4885ALDH1A1 195/4885LMNA 4541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.